Now available is the webcast:
“The Monoclonal Antibody Revolution: What Insurers Need to Know“
Presented by Dr. Daniel Zimmerman,
Senior Vice President, Head of Global Medical, RGA
Join Dr. Daniel Zimmerman, RGA’s Head of Global Medical, as he discusses the fascinating world of monoclonal antibodies and how they are impacting clinical as well as insurance medicine. He will also explain why developments in this area of medical research arenothing short of a revolution. Tune in to learn more about the importance of these specialized immune molecules and their preventative and therapeutic capabilities.